Requirements for Brazilian Outpatient Centers of Excellence in Hidradenitis Suppurativa: Consensus Co-Creative Study
暂无分享,去创建一个
Ericles Andrei Bellei | G. Duarte | R. Magalhães | Roberto Tunala | Camilla Carlini Vallilo | A. Puglia | Felipe Garutti Thies | Roberto Souto da Silva | A. V. Esteves de Carvalho | Barbara Riquena | Miriam Emi Makinodan Shirozaki | Danilo de Barros | E. Y. Tamashiro | Gabriela Cintra | Maria Cecília da Matta Rivitti-Machado | Ricardo Figueiredo do Nascimento | W. G. G. Cesar | Danilo Hamilko de Barros
[1] V. Shi,et al. A practical guide to starting a hidradenitis suppurativa specialty clinic , 2023, JAAD International.
[2] V. Shi,et al. Optimizing hidradenitis suppurativa clinic visits: Patient perspectives , 2022, International Journal of Women's Dermatology.
[3] S. Allender,et al. Co-creation, co-design, co-production for public health - a perspective on definition and distinctions. , 2022, Public health research & practice.
[4] C. Zouboulis,et al. New treatments and new assessment instruments for Hidradenitis suppurativa , 2022, Experimental dermatology.
[5] A. Fekadu,et al. Conceptualising centres of excellence: a scoping review of global evidence , 2022, BMJ Open.
[6] G. Fabbrocini,et al. Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review , 2022, Biomedicines.
[7] S. Lee,et al. A visit guide for adolescent hidradenitis suppurativa: Bridging the divide between pediatric and adult care , 2022, JAAD International.
[8] J. Szepietowski,et al. Indirect Self-Destructiveness in Hidradenitis Suppurativa Patients , 2021, Journal of Clinical Medicine.
[9] F. Sampogna,et al. Pain as Defining Feature of Health Status and Prominent Therapeutic Target in Patients with Hidradenitis Suppurativa , 2021, Journal of clinical medicine.
[10] G. Fabbrocini,et al. Hidradenitis Suppurativa: Where We Are and Where We Are Going , 2021, Cells.
[11] E. Țarcă,et al. Multidisciplinary Management of Adolescents with Hidradenitis Suppurativa – Series of Cases and Literature Review , 2021, Journal of multidisciplinary healthcare.
[12] T. Montero-Vílchez,et al. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis , 2021, International journal of environmental research and public health.
[13] A. Finlay,et al. Quality of Life in Hidradenitis Suppurativa: An Update , 2021, International journal of environmental research and public health.
[14] M. Gilmour,et al. A generative co-design framework for healthcare innovation: development and application of an end-user engagement framework , 2021, Research Involvement and Engagement.
[15] Ericles Andrei Bellei,et al. A Bowling Exergame to Improve Functional Capacity in Older Adults: Co-Design, Development, and Testing to Compare the Progress of Playing Alone Versus Playing With Peers , 2021, JMIR serious games.
[16] A. Beurskens,et al. How to support a co-creative research approach in order to foster impact. The development of a Co-creation Impact Compass for healthcare researchers , 2020, PloS one.
[17] Francesco Schiavone,et al. Re-designing the service experience in the value co-creation process: an exploratory study of a healthcare network , 2020, Bus. Process. Manag. J..
[18] Sven M. Laudien,et al. Co-creation in coworking-spaces: boundary conditions of diversity , 2020 .
[19] Habibolah Khazaie,et al. A Mixed-Method Modified Delphi Study toward Identifying Key Elements of Psychotherapy in Iran , 2020, International journal of environmental research and public health.
[20] Alexander K. Saeri,et al. Research co-design in health: a rapid overview of reviews , 2020, Health Research Policy and Systems.
[21] A. Gottlieb,et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. , 2019, Journal of the American Academy of Dermatology.
[22] A. Gottlieb,et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. , 2019, Journal of the American Academy of Dermatology.
[23] G. Duarte,et al. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology* , 2019, Anais brasileiros de dermatologia.
[24] Yevgeniy Feyman,et al. Association between patient outcomes and accreditation in US hospitals: observational study , 2018, British Medical Journal.
[25] Tanya Marchant,et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution , 2018, The Lancet. Global health.
[26] A. Gottlieb,et al. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process , 2018, The British journal of dermatology.
[27] G. W. Campos. Future prospects for the SUS. , 2018, Ciencia & saude coletiva.
[28] Sheila Leatherman,et al. Delivering Quality Health Services: A Global Imperative for Universal Health Coverage , 2018 .
[29] H. Miot,et al. Prevalence of hidradenitis suppurativa in Brazil: a population survey , 2018, International journal of dermatology.
[30] Pedro Paulo Balestrassi,et al. The Influence of Accreditation on the Sustainability of Organizations with the Brazilian Accreditation Methodology , 2018, Journal of healthcare engineering.
[31] J. Fortenberry,et al. Centers of excellence in healthcare institutions: what they are and how to assemble them , 2017, BMC Health Services Research.
[32] R. Jandarov,et al. Factors Contributing to Depression and Chronic Pain in Patients with Hidradenitis Suppurativa: Results from a Single-Center Retrospective Review , 2017, Dermatology.
[33] J. Bousquet,et al. Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence , 2016, Allergy.
[34] Tina Janamian,et al. Achieving Research Impact Through Co‐creation in Community‐Based Health Services: Literature Review and Case Study , 2016, The Milbank quarterly.
[35] J. Lapins,et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[36] S. Halevy,et al. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[37] A. Mehrotra,et al. Ensuring excellence in centers of excellence programs. , 2015, Annals of surgery.
[38] D. Gheonea,et al. Excellence centers in inflammatory bowel disease in Romania: a measure of the quality of care. , 2014, Journal of gastrointestinal and liver diseases : JGLD.
[39] Kathleen M. MacQueen,et al. Applied Thematic Analysis , 2011 .
[40] M. Angastiniotis,et al. Requirements for a Reference or Expert Thalassemia Center: The Structure/model for Centers Dealing with Chronic/hereditary Blood Disorders , 2009, Hemoglobin.
[41] H. Kurzen,et al. What causes hidradenitis suppurativa? , 2008, Experimental dermatology.
[42] Jeffrey Braithwaite,et al. Health sector accreditation research: a systematic review. , 2008, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[43] N. Arora,et al. Focus group discussions in medical research , 2000, Indian journal of pediatrics.
[44] Human-Centered Service Design for Healthcare Transformation: Development, Innovation, Change , 2023 .
[45] G. Jemec,et al. Increased Suicide Risk in Patients with Hidradenitis Suppurativa. , 2018, The Journal of investigative dermatology.